Philip K. Yachmetz, Co-President and CBO at SAVIENT PHARMACEUTICALS INC (SVNT), sold 213,156 shares at $0.10 ($21K) on 2013-10-15, disclosed to the SEC on 2013-10-17.
Open-market sale of $21k SVNT by Co-President and CBO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.09 | 10,000 | $900 | 4.3% |
| 2 | $0.09 | 20,000 | $2K | 8.6% |
| 3 | $0.10 | 19,745 | $2K | 9.4% |
| 4 | $0.10 | 20,000 | $2K | 9.5% |
| 5 | $0.10 | 40,000 | $4K | 19.0% |
| 6 | $0.10 | 50,000 |
| $5K |
| 23.8% |
| 7 | $0.10 | 53,411 | $5K | 25.4% |
| Total | $0.10 avg | 213,156 | $21K | 100% |
| Filing → |
| SVNT | SELL | 2012-02-23 | $7K | — | Filing → |
| SVNT | BUY | 2011-09-16 | $29K | — | Filing → |
| SVNT | SELL | 2011-02-15 | $32K | — | Filing → |